Exchange: NASDAQ·Updated 07:30 PM EDT

ATTO Attovia Therapeutics Inc.

$17.50
$0.495
(2.75%)
Today
Closed $17.50
$0.00
(0.00%)
After Hours
EarningsNov 11
Mkt Cap$821.49M
Vol521,653.00

About ATTO

Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
35

Bearish Sentiment

How do you feel about ATTO?

Advertisement|Remove ads.